{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:59Z","timestamp":1792791539576,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ICES"},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Western University, and the Lawson Health Research Institute"},{"name":"Medical Oncology Research Fund"},{"name":"Canadian Institute for Health Information"},{"DOI":"10.13039\/100009142","name":"Cancer Care Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jgo.2020.05.009","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T03:32:47Z","timestamp":1593401567000},"page":"1132-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada"],"prefix":"10.1016","volume":"11","author":[{"given":"Phillip S.","family":"Blanchette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britney","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salimah Z.","family":"Shariff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen I.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Desautels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig C.","family":"Earle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jgo.2020.05.009_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2015.124","article-title":"Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?","volume":"12","author":"Zwart","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2020.05.009_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/1073858413519865","article-title":"Estrogen receptors, the hippocampus, and memory","volume":"20","author":"Bean","year":"2014","journal-title":"Neuroscientist"},{"issue":"11","key":"10.1016\/j.jgo.2020.05.009_bb0015","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.jgo.2020.05.009_bb0020","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative memory study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"issue":"9869","key":"10.1016\/j.jgo.2020.05.009_bb0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/j.jgo.2020.05.009_bb0030","article-title":"aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,934 women with early breast cancer","volume":"31","author":"Gray","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2020.05.009_bb0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast Cancer: ASCO clinical practice guideline focused update","volume":"37","author":"Burstein","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2020.05.009_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SPC.0000000000000251","article-title":"Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients","volume":"11","author":"Wu","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"10.1016\/j.jgo.2020.05.009_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40261-015-0364-9","article-title":"The impact of endocrine therapy on cognitive functions of breast Cancer patients: a systematic review","volume":"36","author":"Bakoyiannis","year":"2016","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.jgo.2020.05.009_bb0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-016-3906-9","article-title":"Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies","volume":"158","author":"Lee","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jgo.2020.05.009_bb0055","author":"ICES"},{"issue":"5","key":"10.1016\/j.jgo.2020.05.009_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"10.1016\/j.jgo.2020.05.009_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jgo.2020.05.009_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","article-title":"Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records","volume":"33","author":"Schultz","year":"2013","journal-title":"Chronic Dis Inj Can"},{"issue":"7","key":"10.1016\/j.jgo.2020.05.009_bb0075","first-page":"e225","article-title":"Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD)","volume":"26","author":"Tu","year":"2010","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.jgo.2020.05.009_bb0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jgo.2020.05.009_bb0085","first-page":"e18","article-title":"Accuracy of administrative databases in identifying patients with hypertension","volume":"1","author":"Tu","year":"2007","journal-title":"Open Med"},{"issue":"11","key":"10.1016\/j.jgo.2020.05.009_bb0090","first-page":"1388","article-title":"Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard","volume":"29","author":"Tu","year":"2013","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jgo.2020.05.009_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-160105","article-title":"Identification of physician-diagnosed Alzheimer's disease and related dementias in population-based administrative data: a validation study using family physicians' electronic medical records","volume":"54","author":"Jaakkimainen","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"10113","key":"10.1016\/j.jgo.2020.05.009_bb0100","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jgo.2020.05.009_bb0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1503\/cmaj.070796","article-title":"Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease","volume":"178","author":"Patterson","year":"2008","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jgo.2020.05.009_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-010-1235-y","article-title":"Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and\/or tamoxifen in the BIG 1-98 trial","volume":"126","author":"Phillips","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.jgo.2020.05.009_bb0115","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.2008.21.3553","article-title":"Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial","volume":"28","author":"Schilder","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2020.05.009_bb0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11764-019-00782-w","article-title":"Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK","volume":"13","author":"Bromley","year":"2019","journal-title":"J Cancer Surviv"},{"issue":"2","key":"10.1016\/j.jgo.2020.05.009_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/hcv072","article-title":"Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study","volume":"109","author":"Sun","year":"2016","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.jgo.2020.05.009_bb0130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnci\/94.8.592","article-title":"The effects of tamoxifen and estrogen on brain metabolism in elderly women","volume":"94","author":"Ernst","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jgo.2020.05.009_bb0135","first-page":"899","volume":"150","year":"1994","journal-title":"CMAJ"},{"key":"10.1016\/j.jgo.2020.05.009_bb0140","author":"Canadian Public Health Agency"},{"issue":"3","key":"10.1016\/j.jgo.2020.05.009_bb0145","doi-asserted-by":"crossref","first-page":"e201541","DOI":"10.1001\/jamanetworkopen.2020.1541","article-title":"Association between hormone-modulating breast Cancer therapies and incidence of neurodegenerative outcomes for women with breast Cancer","volume":"3","author":"Branigan","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jgo.2020.05.009_bb0150","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1055-9965.EPI-13-0139","article-title":"Null association between tamoxifen use and dementia in Danish breast cancer patients","volume":"22","author":"Ording","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820300837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820300837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:51:11Z","timestamp":1761817871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406820300837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1879406820300837"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2020.05.009","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2020.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}